These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23353570)

  • 1. The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy.
    Xu SY; Pan SY
    Med Sci Monit Basic Res; 2013 Jan; 19():37-45. PubMed ID: 23353570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches.
    Wahlgren NG; Ahmed N
    Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Past, present and future of neuroprotection].
    Mracek J
    Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].
    Lestage P; Lockhart B; Roger A
    Therapie; 2002; 57(6):554-63. PubMed ID: 12666263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection for ischemic stroke: past, present and future.
    Ginsberg MD
    Neuropharmacology; 2008 Sep; 55(3):363-89. PubMed ID: 18308347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approaches to neuroprotection trials in acute ischemic stroke.
    Tymianski M
    Stroke; 2013 Oct; 44(10):2942-50. PubMed ID: 24021680
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
    Sutherland BA; Minnerup J; Balami JS; Arba F; Buchan AM; Kleinschnitz C
    Int J Stroke; 2012 Jul; 7(5):407-18. PubMed ID: 22394615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction.
    Godínez-Rubí M; Rojas-Mayorquín AE; Ortuño-Sahagún D
    Oxid Med Cell Longev; 2013; 2013():297357. PubMed ID: 23691263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective agents in Acute Ischemic Stroke-A Reality Check.
    Goenka L; Uppugunduri Satyanarayana CR; S SK; George M
    Biomed Pharmacother; 2019 Jan; 109():2539-2547. PubMed ID: 30551514
    [No Abstract]   [Full Text] [Related]  

  • 11. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M; Benatar M; Fisher M; Savitz SI
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
    Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
    Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of NAD
    Huang Q; Sun M; Li M; Zhang D; Han F; Wu JC; Fukunaga K; Chen Z; Qin ZH
    Mol Neurobiol; 2018 Jul; 55(7):6063-6075. PubMed ID: 29164394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia.
    Leker RR; Neufeld MY
    Brain Res Brain Res Rev; 2003 Jun; 42(3):187-203. PubMed ID: 12791439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
    De Keyser J; Sulter G; Luiten PG
    Trends Neurosci; 1999 Dec; 22(12):535-40. PubMed ID: 10542428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review.
    Dhir N; Medhi B; Prakash A; Goyal MK; Modi M; Mohindra S
    Curr Neuropharmacol; 2020; 18(7):596-612. PubMed ID: 31934841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
    Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy in stroke: from preclinical to clinical studies.
    Kaur H; Prakash A; Medhi B
    Pharmacology; 2013; 92(5-6):324-34. PubMed ID: 24356194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic stroke intervention requires mixed cellular protection of the penumbra.
    Barone FC
    Curr Opin Investig Drugs; 2009 Mar; 10(3):220-3. PubMed ID: 19333878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of neuroprotective agents in the treatment of acute ischemic stroke.
    Lutsep HL; Clark WM
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):13-8. PubMed ID: 11898495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.